Catalyst Wire Dossier Catalyst Wire Dossier

guaifenesin and pseudoephedrine combination

· Reckitt Benckiser Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for guaifenesin and pseudoephedrine combination, covering 2012-11-05 to 2012-11-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI [Phase 4]

See pricing